Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relationship of PPARG overexpression with prognostic parameters in papillary thyroid carcinoma. | Acta Otorhinolaryngol Ital | 2022 | 35292786 | PubTator, text mining | PubMed |
| Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow. | Res Pract Thromb Haemost | 2022 | 35284776 | PubTator, text mining | PubMed |
| Corrigendum to "Plasmatic Membrane Expression of Adhesion Molecules in Human Cardiac Progenitor/Stem Cells Might Explain Their Superior Cell Engraftment after Cell Transplantation". | Stem Cells Int | 2022 | 35283998 | PubTator, text mining | PubMed |
| Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer. | Front Oncol | 2022 | 35280796 | PubTator, text mining | PubMed |
| Ruxolitinib ameliorates progressive anemia and improves survival during episodes of emergency granulopoiesis in Fanconi C-/- mice. | Exp Hematol | 2022 | 35278531 | PubTator, text mining | PubMed |
| Clinical and genomic features of Chinese lung cancer patients with germline mutations. | Nat Commun | 2022 | 35273153 | PubTator, text mining | PubMed |
| Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19. | Biomed Pharmacother | 2022 | 35272139 | PubTator, text mining | PubMed |
| Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021. | Cancers (Basel) | 2022 | 35267561 | PubTator, text mining | PubMed |
| Targeting of RecQ Helicases as a Novel Therapeutic Strategy for Ovarian Cancer. | Cancers (Basel) | 2022 | 35267530 | PubTator, text mining | PubMed |
| Talin‑1 interaction network in cellular mechanotransduction (Review). | Int J Mol Med | 2022 | 35266014 | PubTator, text mining | PubMed |
| Detection of germline variants in Brazilian breast cancer patients using multigene panel testing. | Sci Rep | 2022 | 35264596 | PubTator, text mining | PubMed |
| Common Variable Immunodeficiency-Associated Cancers: The Role of Clinical Phenotypes, Immunological and Genetic Factors. | Front Immunol | 2022 | 35250968 | PubTator, text mining | PubMed |
| The Prognostic Value of the Developmental Gene FZD6 in Young Saudi Breast Cancer Patients: A Biomarkers Discovery and Cancer Inducers OncoScreen Approach. | Front Mol Biosci | 2022 | 35237656 | PubTator, text mining | PubMed |
| Case Report: A BRCA2 Mutation Identified Through Next-Generation Sequencing in a Birt-Hogg-Dubè Syndrome Family. | Front Oncol | 2022 | 35237525 | PubTator, text mining | PubMed |
| PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components. | Onco Targets Ther | 2022 | 35237050 | PubTator, text mining | PubMed |
| Pancreatic cancer risk to siblings of probands in bilineal cancer settings. | Genet Med | 2022 | 35227607 | PubTator, text mining | PubMed |
| Integrated molecular profiling of patient-derived ovarian cancer models identifies clinically relevant signatures and tumor vulnerabilities. | Int J Cancer | 2022 | 35218560 | PubTator, text mining | PubMed |
| Fanconi Anemia Patients from an Indigenous Community in Mexico Carry a New Founder Pathogenic Variant in FANCG. | Int J Mol Sci | 2022 | 35216452 | PubTator, text mining | PubMed |
| How Fear of COVID-19 Affects the Behavioral Intention of Festival Participants-A Case of the HANFU Festival. | Int J Environ Res Public Health | 2022 | 35206321 | PubTator, text mining | PubMed |
| Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes. | Biomedicines | 2022 | 35203410 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=30